Results
|
98721.
|
|
|
98722.
|
|
|
98723.
|
|
|
98724.
|
A response to the commentary "The role of mineralocorticoid receptor dysregulation in the neurocognitive impairment of patients recovered from depression" by Preston, S., Watson, S. and Gallagher, P. on "Associations between cognitive performance and cortisol reaction to the DEX/CRH test in patients recovered from depression" by Behnken, A., Bellingrath, S., Symanczik, J. P., Rieck, M. J., Zavorotnyy, M., Domschke, K., Arolt, V., & Zwanzger, P. doi: 10.1016/j.psyneuen.2012.07.005. [electronic resource] by Producer: 20140403
In:
Psychoneuroendocrinology vol. 38
Availability: No items available.
|
|
98725.
|
|
|
98726.
|
|
|
98727.
|
|
|
98728.
|
|
|
98729.
|
|
|
98730.
|
A pragmatic pilot randomized trial to investigate the effectiveness of behavioural activation group therapy in reducing depressive symptoms and improving quality of life in patients with depression: the BRAVE pilot trial protocol. [electronic resource] by
- Samaan, Zainab
- Litke, Kathryn
- McCabe, Kathleen
- Dennis, Brittany
- Whattam, Jeff
- Garrick, Laura
- O'Neill, Laura
- Tabak, Terri Ann
- Simons, Scott
- Chalmers, Sandra
- Key, Brenda
- Vanstone, Meredith
- Xie, Feng
- Guyatt, Gordon
- Thabane, Lehana
Publication details: Pilot and feasibility studies 2015
In:
Pilot and feasibility studies vol. 1
Availability: No items available.
|
|
98731.
|
Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study. [electronic resource] by
- Canuso, Carla M
- Singh, Jaskaran B
- Fedgchin, Maggie
- Alphs, Larry
- Lane, Rosanne
- Lim, Pilar
- Pinter, Christine
- Hough, David
- Sanacora, Gerard
- Manji, Husseini
- Drevets, Wayne C
Publication details: Focus (American Psychiatric Publishing) Jan 2019
In:
Focus (American Psychiatric Publishing) vol. 17
Availability: No items available.
|
|
98732.
|
|
|
98733.
|
|
|
98734.
|
|
|
98735.
|
|
|
98736.
|
|
|
98737.
|
Quality of life, depression and fatigue in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: 3-year results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study. [electronic resource] by
- Patti, F
- Amato, M P
- Trojano, M
- Bastianello, S
- Tola, M R
- Picconi, O
- Cilia, S
- Cottone, S
- Centonze, D
- Gasperini, C
Producer: 20111121
In:
Multiple sclerosis (Houndmills, Basingstoke, England) vol. 17
Availability: No items available.
|
|
98738.
|
|
|
98739.
|
|
|
98740.
|
|